Buy Crypto Markets Spot FuturesIOST Earn Event Centre Rewards Hub

Bristol-Myers Squibb Co. (BMY)

NYSE

$64,00

$+0,13

(+0,20%)

Pre-Market

Bristol-Myers Squibb Co. (BMY) Live Price Chart

Last updated: ⁦2026-09-11 08:18:00⁩. Prices reflect the latest pre-market trading data. Stock price data is sourced from Massive.

Summary

Bristol-Myers Squibb Co. (BMY) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NYSE. The stock is currently priced at $64,00, with a market capitalisation of $131,57B and a P/E ratio of 14,03. Over the past 52 weeks, its price has ranged from $42,52 to $68,64. This page covers its latest market performance, valuation, price trends and company information.

Key Market Data

Market Cap	$131,57B
Open	$63,88
Day's High	$81,44
Day's Low	$16,00
Previous Close	$63,75
Volume	32,00
Average Volume	11,24M
P/E Ratio	14,03
52-Week High	$68,64
52-Week Low	$42,52
Dividend Yield	3,91%
Earnings Date	--

Bristol-Myers Squibb Co. (BMY) Pre-Market Stock Price

Bristol-Myers Squibb Co. (BMY) is trading at $64,00 in pre-market trading as of 2026-09-11 08:07:00, up 0,39% ($0,25) from the previous close of $63,75

Pre-market trading shows how investors are pricing BMY before the regular session opens. The current pre-market price is near the previous close, indicating positive early trading sentiment.

Bristol-Myers Squibb Co. (BMY) 7-Day Stock Price Change

Over the past seven days, Bristol-Myers Squibb Co. (BMY) moved from $66,92 to $64,00, representing a decline of 4,36% ($2,92).

The stock traded between $63,73 and $68,24 during the period. The latest price is near the lower end of the 7-day range, indicating moderate downward.

The average daily volume was 6,91 million shares, down versus the previous seven-day period, indicating lower trading activity.

BMY 52-Week Price Position

Position in Range: 82,2%

52W Low$42,52

52W High$68,64

BMY is currently trading at $64,00, placing it 82,2% of the way from its 52-week low of $42,52 to its 52-week high of $68,64. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.

What is Bristol-Myers Squibb Co. (BMY)?

Bristol Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Bristol derives close to 70% of total sales from the US, showing a higher dependence on the US market than most of its peer group.

Bristol-Myers Squibb Co. Information

Industry	PHARMACEUTICAL PREPARATIONS
Employees	32500
Exchange	NYSE
Company Website	https://www.bms.com

How to Buy Bristol-Myers Squibb Co. (BMY) Stock on MEXC

Eligible investors can buy real shares of Bristol-Myers Squibb Co. (BMY) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.

Step 1: Open and Verify Your RealStocks Account

Log in to the MEXC App, go to Trade → RealStocks, and select Open Account. Complete the required account-opening and identity verification process with MEXC's partner licenced broker.

Step 2: Transfer USDT to Your RealStocks Account

Go to Wallets → RealStocks and transfer USDT from your Spot Account to your RealStocks Account. RealStocks are quoted in USD, while account funding can be completed using USDT.

Step 3: Search for BMY and Place Your Order

Open the RealStocks trading page and search for BMY. Select a market or limit order, enter the price and quantity as required, review the order details, and submit your order. Once filled, the corresponding real shares will be held in your RealStocks Account.

Frequently Asked Questions (FAQ)

1.What is Bristol-Myers Squibb Co. (BMY) stock price today?

Bristol-Myers Squibb Co. (BMY) is currently trading at $ 64,00, up 0,39% ($0,25) from the previous close of $ 63,75. Intraday prices update in real time during regular trading hours.

2.Is BMY stock going up or down today?

As of 2026-09-11 08:07:00, BMY is trading at $ 64,00, up 0,39% ($0,25) from its previous close of $ 63,75. The stock has traded between $ 16,00 and $ 81,44 during today’s regular session. Past price movements do not guarantee future results.

3.What is BMY pre-market price?

As of 2026-09-11 08:07:00, BMY is trading at $ 64,00 in pre-market trading, up 0,39% ($0,25) from the previous close of $ 63,75. Pre-market prices reflect trading activity before the regular session opens and may experience lower liquidity and higher volatility.

4.What is BMY after-hours price?

As of 2026-09-11 08:07:00, BMY is trading at $ 63,87 in after-hours trading, up 0,19% ($0,12) from the regular-session close of $ 63,75. After-hours prices may differ from the regular session’s opening price due to lower liquidity and wider bid-ask spreads.

5.Is BMY stock trading now?

BMY trades on the NYSE exchange during regular hours, Monday through Friday, 9:30 AM to 4:00 PM ET, excluding public holidays. Pre-market and after-hours trading are also available through select brokers outside these hours.

6.Where does BMY sit relative to its 52-week high and low?

Over the past 52 weeks, BMY has traded between a low of $ 42,52 and a high of $ 68,64. At $ 64,00, the stock is positioned 82,2% of the way from its 52-week low to its 52-week high, providing context for its current price within the one-year trading range.

7.What sector is Bristol-Myers Squibb Co. in?

Bristol-Myers Squibb Co. (BMY) operates in the PHARMACEUTICAL PREPARATIONS sector. Sector classification helps investors compare it with companies exposed to similar market trends and competitive conditions.

8.What is Bristol-Myers Squibb Co.'s market capitalisation and where is it listed?

Bristol-Myers Squibb Co. is listed on the NYSE exchange with a market capitalisation of $ 131,57B. Market cap reflects the total market value of all outstanding shares and is commonly used to classify stocks by size.

9.How is BMY valued in terms of P/E ratio and EPS?

BMY trades at a P/E ratio of 14,03, based on trailing-twelve-month EPS of $ 4,54. P/E ratio compares the stock price to earnings per share and is a common starting point for assessing valuation relative to peers.

10.Does Bristol-Myers Squibb Co. pay a dividend?

Bristol-Myers Squibb Co. pays an indicated annual cash dividend of $ 2,50 per share, with a current dividend yield of 3,91% based on the latest share price. Dividend policies are subject to change at the board's discretion.